Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RINGQUEST: Exploring Understudied Genitourinary Tumors With Sacituzumab Tirumotecan; a Single-arm, Basket, Phase II Study

NCT07716917 is registered in ClinicalTrials.gov with Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD as lead sponsor.

NCT NCT07716917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07716917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RINGQUEST: Exploring Understudied Genitourinary Tumors With Sacituzumab Tirumotecan; a Single-arm, Basket, Phase II Study
Lead sponsor
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
December 31, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

papillary renal carcinoma, variant histology urothelial carcinoma